Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 11(1): 1677, 2020 04 03.
Article in English | MEDLINE | ID: mdl-32245952

ABSTRACT

Human stem cell-derived hepatocyte-like cells (HLCs) offer an attractive platform to study liver biology. Despite their numerous advantages, HLCs lack critical in vivo characteristics, including cell polarity. Here, we report a stem cell differentiation protocol that uses transwell filters to generate columnar polarized HLCs with clearly defined basolateral and apical membranes separated by tight junctions. We show that polarized HLCs secrete cargo directionally: Albumin, urea, and lipoproteins are secreted basolaterally, whereas bile acids are secreted apically. Further, we show that enterically transmitted hepatitis E virus (HEV) progeny particles are secreted basolaterally as quasi-enveloped particles and apically as naked virions, recapitulating essential steps of the natural infectious cycle in vivo. We also provide proof-of-concept that polarized HLCs can be used for pharmacokinetic and drug-drug interaction studies. This novel system provides a powerful tool to study hepatocyte biology, disease mechanisms, genetic variation, and drug metabolism in a more physiologically relevant setting.


Subject(s)
Cell Culture Techniques/methods , Cell Polarity , Hepatocytes/physiology , Induced Pluripotent Stem Cells/physiology , Antiviral Agents/pharmacology , Cell Differentiation , Cells, Cultured , Drug Evaluation, Preclinical/methods , Drug Interactions , Hepatitis A Virus, Human/physiology , Hepatitis E virus/physiology , Hepatocytes/ultrastructure , Hepatocytes/virology , Humans , Liver/cytology , Liver/metabolism , Membrane Transport Proteins/metabolism , Microscopy, Electron, Transmission , Proof of Concept Study , Virion/metabolism , Virus Release , Virus Replication
2.
Planta Med ; 76(9): 882-8, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20104443

ABSTRACT

The essential oil (EO) of Thymus x viciosoi (Pau) R. Morales was isolated and analysed by GC and GC-MS. The antifungal activity of the EO and its major components against clinically relevant yeasts and molds was then measured. Their influence on the germ tube formation in Candida albicans and the influence of the EO on the metabolic function and cytoplasmic membrane integrity in the same yeast, analyzed by flow cytometry, were also studied. The EO showed high contents of carvacrol, thymol, and P-cymene. The total EO, as well as its components carvacrol and thymol, displayed very low minimum inhibitory concentrations and minimum fungicidal concentrations against all tested organisms (0.04 to 0.64 microL mL(-1)), while P-cymene showed weaker activity (2.5 to > 20.0 microL mL(-1)). They also inhibited filamentation at sub-inhibitory concentrations in C. albicans, particularly P-cymene, and the EO led to rapid metabolic arrest, disruption of the plasma membrane and consequently cell death. The EO and its main components were found to display a broad fungicidal activity through the disruption of cytoplasmic membrane integrity leading to leakage of vital intracellular compounds. In conclusion, the phenolic oil of T. x viciosoi may have potential for use in the development of clinically useful antifungal preparations.


Subject(s)
Antifungal Agents/pharmacology , Arthrodermataceae/drug effects , Candida/drug effects , Cryptococcus/drug effects , Oils, Volatile/pharmacology , Plant Extracts/pharmacology , Thymus Plant/chemistry , Antifungal Agents/isolation & purification , Arthrodermataceae/metabolism , Arthrodermataceae/ultrastructure , Candida/metabolism , Candida/ultrastructure , Cryptococcus/metabolism , Cryptococcus/ultrastructure , Microbial Sensitivity Tests , Oils, Volatile/chemistry , Oils, Volatile/isolation & purification , Plant Extracts/chemistry
3.
Mycoses ; 49(4): 261-73, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16784439

ABSTRACT

The current increase in the number and significance of fungal infections, the expanding armamentarium of antifungal agents, and the emergence of the problem of antifungal drug resistance have been intensifying the importance of antifungal susceptibility testing (AST). The Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) in the United States and the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) published standard methodologies in order to achieve higher reproducibility and allow direct inter-laboratory comparison of the susceptibility results. Nevertheless, several problems remain unresolved and the methods depend on long incubation periods of a minimum of 24 h (EUCAST) or even 48 h (CLSI). Over the last 15 years, successful applications of flow cytometric techniques to AST of both yeast and moulds have been reported. These techniques are based on the analysis of a great number of fungal cells individually and frequently rely on short incubation times of no more than a few hours. Considering these attributes, flow cytometry (FC) seems to have the potential to achieve clinical usefulness in the near future. The collection of data on the reproducibility of the results and on the correlation with clinical outcomes has barely started, however. Practical validation of the experimental methodologies is not granted before a significant amount of data addressing those questions is available.


Subject(s)
Flow Cytometry/methods , Fungi/drug effects , Microbial Sensitivity Tests/methods , Ergosterol/biosynthesis , Fluorescent Dyes , Reagent Kits, Diagnostic , Yeasts/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...